Literature DB >> 33112110

Gastrointestinal stromal tumors of the colon and rectum.

Alexandra Roşulescu1,2, Nicolae Pechianu1,3,4, Monica Hortopan1, Mihaela Mihai1, Simona Dima4,5, Cezar Stroescu5, Radu Zamfir5, Vladislav Braşoveanu2,5, David Leonard5, Cătălin Vasilescu2,5, Irinel Popescu3,4,5, Vlad Herlea1,3,4.   

Abstract

Gastrointestinal stromal tumors (GISTs) are rare neoplasms, colorectal location being met in less than 5% of cases. Knowledge about this site related particularities are limited. The aim of this study is to present our experience with colorectal GISTs between 2005 and 2018 from the clinical, morphological, and immunohistochemical perspectives, with emphasis on prognostic factors. From a total of 203 gastrointestinal stromal tumors registered, 12 were colorectal (6%). The number of colonic tumors surpassed that of the rectum (9 : 3) and on the right side were registered more cases than on the left side (6/3). 9 were primary tumors and 3 were recurrences. Men and women were represented equally and the age range was between 22 and 76. Tumor dimensions varied between 0.5 and 14 cm. Microscopically, spindle cell type was dominant. Mitotic rate was variable between 1 and 115/50HPFs. Accordingly, for primary tumors progression risks were assigned (low risk: 2 cases, intermediate risk: 3 cases and high risk: 4 cases). All GISTs were CD117 and DOG1 positive. Four of the patients died of the disease.

Entities:  

Keywords:  colon; histopathology; immunohistochemistry; rectum; gastrointestinal stromal tumor

Mesh:

Substances:

Year:  2020        PMID: 33112110     DOI: 10.5114/pjp.2020.99786

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  1 in total

1.  Development of an innovative nomogram of risk factors to predict postoperative recurrence of gastrointestinal stromal tumors.

Authors:  Shi-Hao Guan; Qiong Wang; Xiao-Ming Ma; Wen-Jie Qiao; Ming-Zheng Li; Ming-Gui Lai; Cheng Wang
Journal:  World J Gastrointest Surg       Date:  2022-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.